by plexusventures_h3tnl0 | Jan 11, 2021 | Uncategorized
Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful conclusion of a licensing agreement of behalf of our client, Glenmark Pharmaceuticals. Mr. Michael O’Sullivan, Plexus Ventures’ Managing Partner, stated: “This transaction is an ideal...
by plexusventures_h3tnl0 | Apr 7, 2020 | Featured
Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the completion of a divestiture project on behalf of its client, Glenmark Pharmaceuticals Ltd. Plexus Ventures advised Glenmark on the sale of a CNS product portfolio and sales team to Neuraxpharm....
by plexusventures_h3tnl0 | Mar 1, 2020 | Uncategorized
Philadelphia, Pennsylvania – Plexus Ventures announces the appointment of Olessia Kamp, based near Frankfurt, as Senior Advisor in Germany. Prior to joining Plexus, Olessia served for nearly 15 years at Berlin-Chemie AG, a subsidiary of Menarini, focusing from German...
by plexusventures_h3tnl0 | Sep 1, 2019 | Uncategorized
Philadelphia, Pennsylvania – Plexus Ventures announces the appointment of Dr. Daniel Sieiro Mosti as Scientific Associate. Dr. Sieiro is a former research fellow at Harvard Medical School where he focused on the genetic basis of tissue development in health and...
Recent Comments